|
10 Dec 2010 |
Spinal Cord Injury Patient Treated With Non-Matched Adult Stem Cells
|
|
08 Dec 2010 |
MESOBLAST AND CEPHALON ENTER INTO STRATEGIC ALLIANCE TO COMMERCIALIZE NOVEL THERAPEUTIC PRODUCTS FOR REGENERATIVE MEDICINE
|
|
07 Dec 2010 |
Cytori Therapeutics Enters Strategic Equity Deal With Astellas Pharma; To Sell $10 Million in Equity at $7.00 per Share
|
|
07 Dec 2010 |
StemCells, Inc. Receives Authorization to Conduct World's First Neural Stem Cell Trial in Spinal Cord Injury
|
|
06 Dec 2010 |
Idera Presents Preclinical Data on Dual Agonist of TLR7 and TLR8, IMO-4200, at American Society for Hematology Meeting
|
|
02 Dec 2010 |
Sirnaomics Seals Partnership Deal for Development of RNAi Therapeutics in China
|
|
02 Dec 2010 |
Amsterdam Molecular Therapeutics Amends Amgen GDNF Gene License Agreement
|
|
02 Dec 2010 |
Geron Initiates Randomized Phase 2 Clinical Trial of Imetelstat in Breast Cancer
|
|
30 Nov 2010 |
miRagen Therapeutics and t2cure Sign Licensing Agreement for microRNA Target Implicated in Vascular Disease
|
